CoChat

Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans

Open access
Piotrowski, Katja, Becker, Melanie, Zugwurst, Julia, Biller-Friedmann, Ingeborg, Spoettl, Gerald, Greif, Martin, Leber, Alexander W, Becker, Alexander, Laubender, Rüdiger P, Lebherz, Corinna, Goeke, Burkhard, Marx, Nikolaus, Parhofer, Klaus G, Lehrke, Michael · 2013 · Cardiovascular Diabetology
Cited by 42

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background: GLP-1 is an incretine hormone which gets secreted from intestinal L-cells in response to nutritional stimuli leading to pancreatic insulin secretion and suppression of glucagon release. GLP-1 further inhibits gastric motility and reduces appetite which in conjunction improves postprandial glucose metabolism. Additional vasoprotective effects have been described for GLP-1 in experimental models. Despite these vasoprotective actions, associations between endogenous levels of GLP-1 and cardiovascular disease have yet not been investigated in humans which was the aim of the present study. Methods: GLP-1 serum levels were assessed in a cohort of 303 patients receiving coronary CT-angiography due to typical or atypical chest pain. Results: GLP-1 was found to be positively associated with total coronary plaque burden in a fully adjusted model containing age, sex, BMI, hypertension, diabetes mellitus, smoking, triglycerides, LDL-C (low density lipoprotein cholesterol), hsCRP (high-sensitive C-reactive protein), and eGFR (estimated glomerular filtration rate) (OR: 2.53 (95% CI: 1.12 – 6.08; p = 0.03). Conclusion: Circulating GLP-1 was found to be positivity associated with coronary atherosclerosis in humans. The clinical relevance of this observation needs further investigations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1475-2840-12-117

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 42

Metadata

Authors
Piotrowski, K., Becker, M., Zugwurst, J., Biller-Friedmann, I., Spoettl, G., Greif, M., Leber, A. W., Becker, A., Laubender, R. P., Lebherz, C., Goeke, B., Marx, N., Parhofer, K. G., & Lehrke, M.
Venue
Cardiovascular Diabetology
Published
2013-08-16
Volume
12
Issue
1
Pages
117-117
ISSN
1475-2840 (ISSN-L)
OpenAlex
W2138199595
Cited by
42
References
6
FWCI
3.30
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans. https://app.cochat.ai/papers/10.1186/1475-2840-12-117
The paper
Piotrowski, K., Becker, M., Zugwurst, J., Biller-Friedmann, I., Spoettl, G., Greif, M., Leber, A. W., Becker, A., Laubender, R. P., Lebherz, C., Goeke, B., Marx, N., Parhofer, K. G., & Lehrke, M. (2013). Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans. Cardiovascular Diabetology. https://doi.org/10.1186/1475-2840-12-117

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.